Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SAB Biotherapeutics (SABS)
NASDAQ:SABS
RESEARCH TOOLSreports
Holding SABS?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ 263.14K | $ 944.58K | - | $ 85.52K |
| Gross Profit | - | $ 263.14K | $ 944.58K | $ 1.27M | $ 85.52K |
| EBIT | $ -10.28M | $ -7.24M | $ -4.95M | $ -5.03M | $ -6.81M |
| EBITDA | $ -9.32M | $ -6.10M | $ -3.05M | $ -4.05M | $ -5.91M |
| Net Income Common Stockholders | $ -10.35M | $ -7.34M | $ -5.03M | $ -5.10M | $ -6.88M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 30.40M | $ 37.33M | $ 44.06M | $ 2.43M | $ 7.77M |
| Total Assets | $ 53.80M | $ 61.89M | $ 71.37M | $ 28.34M | $ 35.44M |
| Total Debt | $ 4.52M | $ 5.34M | $ 5.45M | $ 4.65M | $ 4.90M |
| Net Debt | $ -25.88M | $ -31.98M | $ -38.61M | $ 2.23M | $ -2.87M |
| Total Liabilities | $ 16.89M | $ 15.77M | $ 18.55M | $ 13.08M | $ 15.73M |
| Stockholders Equity | $ 36.90M | $ 46.12M | $ 52.82M | $ 15.26M | $ 19.72M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -6.39M | $ -7.77M | $ -10.88M | $ -5.25M | $ -4.92M |
| Operating Cash Flow | $ -6.29M | $ -7.72M | $ -10.75M | $ -5.17M | $ -4.90M |
| Investing Cash Flow | $ -1.15M | $ 11.22M | $ -31.36M | $ -40.86K | $ -22.68K |
| Financing Cash Flow | $ -674.13K | $ -321.04K | $ -394.42K | $ -140.31K | $ -363.79K |